DSIP for Sleep: What the Evidence Shows
What human and animal studies show about DSIP for sleep, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 76
- PubMed records, our ledger
- Animal studies
- 306
- PubMed records, our ledger
- Studies we summarised
- 9
- with an outcome for sleep
Evidence for sleep
Each row is an outcome related to sleep from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Anaesthetic depth (BIS) | DSIP lightened anaesthetic depth (higher BIS, less delta rhythm) and raised heart rate; the opposite of the hypnotic effect predicted. | Human RCTn = 24 | European journal of anaesthesiology 2009, PMID 19142086 |
| Sleep efficiency and latency | Polysomnography showed higher sleep efficiency and shorter sleep latency with DSIP than placebo. | Human RCTn = 16 | Neuropsychobiology 1992, PMID 1299794 |
| Overall therapeutic benefit | The authors concluded short-term DSIP is unlikely to be of major therapeutic benefit in chronic insomnia; subjective sleep quality did not change. | Human RCTn = 16 | Neuropsychobiology 1992, PMID 1299794 |
| Sleep time and clinical significance | Sleep improved slightly under DSIP but the authors judged it of little clinical significance. | Human controlled trial | International journal of clinical pharmacology research 1987, PMID 3583493 |
| Night sleep | DSIP substantially improved night sleep with the first and with repeated doses. | Human controlled trialn = 14 | European neurology 1987, PMID 3622582 |
| Daytime alertness | Daytime alertness and performance increased significantly. | Human controlled trialn = 14 | European neurology 1987, PMID 3622582 |
| Sleep normalisation in insomniacs | Four consecutive injections normalised disturbed sleep in insomniacs in this early series. | Human controlled trial | Neuropsychobiology 1983, PMID 6689058 |
| Latency and duration | Sleep induction took about 1 hour to start and effects lasted up to 20 hours. | Human controlled trial | Neuropsychobiology 1983, PMID 6689058 |
| Total sleep time | Median total sleep time rose by 59% in the 130 minutes after a morning DSIP infusion versus placebo. | Human controlled trialn = 6 | International journal of clinical pharmacology, therapy, and toxicology 1981, PMID 6895513 |
| Plasma DSIP-like immunoreactivity | Endogenous DSIP-like immunoreactivity did not differ significantly between groups. | Human observationaln = 30 | Peptides 1995, PMID 8532601 |
| Sleep duration and quality | Longer, less interrupted sleep with no day-time sedation or other side effects in 6 insomniacs after a single dose. | Human uncontrolled trialn = 6 | Experientia 1981, PMID 7028502 |
| Sleep promotion by DSIP fusion peptide | A DSIP fusion peptide restored neurotransmitter imbalance better than DSIP alone and may enhance sleep in insomniac mice. | Animal · mouse (not a human result) | Frontiers in pharmacology 2024, PMID 39444618 |
PubMed records for DSIP and sleep: 76 human, 306 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What insomnia is
MedlinePlus describes insomnia as trouble falling asleep, staying asleep, or both, leaving a person without refreshing sleep.[10]
It counts insomnia as chronic once it lasts a month or longer, and says most chronic cases are secondary to another problem.[10]
What the DSIP sleep trials measured
PubMed counts 76 human-only and 306 animal papers on DSIP with sleep or insomnia terms, including 5 tagged randomized trials.
Calculated from pubmed query ("delta sleep-inducing peptide"[tiab] OR emideltide[tiab] OR (DSIP[tiab] AND (peptide*[tiab] OR sleep*[tiab]))) AND (sleep*[tiab] OR insomni*[tiab]); date 2026-10-02; human filter count 102; human only count 76; animal filter count 306; randomized filter count 5. Formula: counts as recorded in the goals.json ledger (PubMed [tiab] query with the human, animal and RCT filters shown)
In a trial in chronic insomnia, objective measures showed higher sleep efficiency and shorter sleep latency with DSIP than with placebo.[2]
The same trial's authors concluded that, because none of the other measures including subjective sleep quality changed, short-term treatment was not likely to be of major benefit.[2]
Another controlled trial reported that DSIP substantially improved night sleep with the first and repeated doses.[4]
An earlier controlled trial concluded that sleep improvement under DSIP was of little clinical significance.[3]
An early study reported a 59% rise in median total sleep time within 130 minutes versus placebo.[6]
Does the body's own DSIP track sleep disorders?
A study comparing normal controls, sleep apnea patients and narcolepsy patients found no significant differences in DSIP-like immunoreactivity between the three groups.[7]
A 2009 randomized trial under anaesthesia
In a randomized trial under isoflurane anaesthesia, DSIP significantly increased heart rate and, paradoxically, significantly reduced delta rhythm.[1]
Anti-doping status
WADA's catch-all class prohibits at all times any substance not addressed elsewhere on the list and without current approval by a health authority for human therapeutic use.[11]
Other peptides people research for sleep
All peptides for sleep, comparedCommon questions
Does DSIP help with sleep?
The strongest study we summarise for sleep is human rct evidence, across 9 studies with an outcome for sleep. A trial result is not an approval; see the legal status.
Is DSIP approved for sleep?
No. DSIP is not FDA approved for any use, including sleep.
What is the best peptide for sleep?
There is no single answer. Our sleep overview compares each candidate by evidence grade and legal status rather than by popularity.
Does DSIP help you sleep?
Older small human trials disagree: some report better night sleep, while the best-controlled insomnia trial judged short-term benefit unlikely to be major.[2]
What counts as chronic insomnia?
MedlinePlus says insomnia lasting a month or longer is chronic, and most chronic cases come from another cause.[10]
More on DSIP
Sources
- 1Delta sleep-inducing peptide alters bispectral index, the electroencephalogram and heart rate variability when used as an adjunct to isoflurane anaesthesia.European journal of anaesthesiology · 2009PMID 19142086Accessed 2 Oct 2026
- 2Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.Neuropsychobiology · 1992PMID 1299794Accessed 2 Oct 2026
- 3Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.International journal of clinical pharmacology research · 1987PMID 3583493Accessed 2 Oct 2026
- 4Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.European neurology · 1987PMID 3622582Accessed 2 Oct 2026
- 5Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep.Neuropsychobiology · 1983PMID 6689058Accessed 2 Oct 2026
- 6Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior.International journal of clinical pharmacology, therapy, and toxicology · 1981PMID 6895513Accessed 2 Oct 2026
- 7Delta sleep-inducing peptide in normal humans and in patients with sleep apnea and narcolepsy.Peptides · 1995PMID 8532601Accessed 2 Oct 2026
- 8The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.Experientia · 1981PMID 7028502Accessed 2 Oct 2026
- 9Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models.Frontiers in pharmacology · 2024PMID 39444618Accessed 2 Oct 2026
- 10medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
- 11World Anti-Doping Code International Standard Prohibited List 2026 (in effect 1 January 2026)World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
Found an error? Report a correction.